Cervical Dystonia (CD) is a chronic neurological disorder characterized by involuntary contractions of the cervical musculature that lead to abnormal movements and postures of the head. In some cases, these abnormal contractions may be sustained or continuous; in others, they may be present as spasms that can resemble a tremor.
The pattern of neck muscle involvement in patients with Cervical Dystonia (CD) is variable, leading to clinically heterogeneous directional presentations, such as torticollis, laterocollis, retrocollis, or anterocollis. Individuals may also have additional signs and symptoms, such as shoulder elevation, neck/shoulder pain, head oscillation due to dystonic tremor produced by uneven contractions of the cervical muscles, arm tremor, and use sensory tricks.
According to the National Organizations of Rare Disorders (NORD), cervical dystonia affects women approximately twice as often as men. It is the most common form of focal dystonia in an office setting.
Get FREE sample copy at:
https://www.delveinsight.com/sample-request/cervical-dystonia-market
The Cervical Dystonia market report also covers emerging drugs, current treatment practices, Cervical Dystonia market share of the individual therapies, current and forecasted Cervical Dystonia Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Cervical Dystonia treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Cervical Dystonia Market Key Facts
The prevalence of CD in the United States is estimated to be around 400 per 100,000 and a recently published meta-analysis of primary dystonia suggested an overall CD prevalence of about 50 per million. (Jankovic J et al 2007, Steeves TD, 2012)
In Southern Italy, cervical dystonia was commonest in patients aged 35–54 years with a prevalence of 44.8 per 1,000,000 (Anna Maria Papantonio et al, 2009).
Despite the greater prevalence in females, several studies have reported that CD developed at an earlier age in males than in females (Giovanni Defazio et al, 2013).
Key Benefits of Cervical Dystonia Market Report
-
Cervical Dystonia market report provides an in-depth analysis of Cervical Dystonia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Cervical Dystonia market report will help in developing business strategies by understanding the Cervical Dystonia Market trends & developments, key players and future market competition that will shape and drive the Cervical Dystonia market in the upcoming years.
-
The Cervical Dystonia market report covers Cervical Dystonia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Cervical Dystonia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Cervical Dystonia Market
Cervical Dystonia market size is expected to increase during the forecast period owing to the extensive research and development activities of pharmaceutical companies involved in developing the Therapies.
The Cervical Dystonia market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Cervical Dystonia market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Cervical Dystonia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Cervical Dystonia Epidemiology
The Cervical Dystonia epidemiology section covers insights about historical and current Cervical Dystonia patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Cervical Dystonia Drugs Uptake and Key Market Players
The Cervical Dystonia Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Cervical Dystonia market or expected to get launched in the market during the study period. The analysis covers Cervical Dystonia market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Cervical Dystonia Companies:
Revance Therapeutics
Addex Therapeutics
Medytox
Ipsen
Allergan
And many others.
Cervical Dystonia Therapies Covered in the Report Include:
Botox (OnabotulinumtoxinA
RT002
Dipraglurant-ER
And many others.
Table of Content
1. Key Insights
2. Executive Summary
3. Cervical Dystonia Competitive Intelligence Analysis
4. Cervical Dystonia Market Overview at a Glance
5. Cervical Dystonia Disease Background and Overview
6. Cervical Dystonia Patient Journey
7. Cervical Dystonia Epidemiology and Patient Population
8. Cervical Dystonia Treatment Algorithm, Current Treatment, and Medical Practices
9. Cervical Dystonia Unmet Needs
10. Key Endpoints of Cervical Dystonia Treatment
11. Cervical Dystonia Marketed Products
12. Cervical Dystonia Emerging Therapies
13. Cervical Dystonia Seven Major Market Analysis
14. Attribute Analysis
15. Cervical Dystonia Market Outlook (7 major markets)
16. Cervical Dystonia Access and Reimbursement Overview
17. KOL Views on the Cervical Dystonia Market.
18. Cervical Dystonia Market Drivers
19. Cervical Dystonia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Related Reports
Cervical Dystonia Epidemiology Forecast
DelveInsight's Cervical Dystonia - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Cervical Dystonia in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Cervical Dystonia Pipeline Insights
Cervical Dystonia Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Cervical Dystonia market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd. 2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
